Home SAVA
29.88
  Price0.98%   +0.29
(After Hours: 29.2188 -0.6612 -2.21% )
loading

Cassava Sciences Inc (SAVA) Latest News

Feb-06-23 02:12AM Biogen: What To Do Ahead Of Q4 2022 Financial ReportSeeking Alpha
Feb-01-23 08:55AM 3 Big Reasons to Sell Cassava Sciences Stock Right NowThe Motley Fool
Jan-31-23 06:50AM Darktrace stock falls after New York short seller takes stakeMarketWatch
Jan-30-23 02:20AM Cassava Sciences And Alzheimer's Disease: Unravelling The DataSeeking Alpha
Jan-24-23 07:54AM Tesla, Amazon, Microsoft, Cassava Sciences, Intuitive Surgical: Why These 5 Stocks Are Drawing Investors' Attention TodayBenzinga
01:11AM Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionBenzinga
Jan-24-23 10:59AM 3M, Magna International And Other Big Stocks Moving Lower On TuesdayBenzinga
10:07AM Dow Drops 100 Points; Verizon Issues Weak Earnings ForecastBenzinga
Jan-24-23 09:15AM Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s DiseaseGlobeNewswire Inc.
Jan-12-23 09:40AM Is Mesa Laboratories (MLAB) Outperforming Other Medical Stocks This Year?Zacks Investment Research
Dec-22-22 01:13AM Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day SessionBenzinga
Dec-20-22 09:15AM Cassava Sciences Mourns the Death of Board Member and Officer Nadav Friedmann, PhD, MDGlobeNewswire Inc.
Dec-13-22 09:45AM Is Anavex Life Sciences a Buy?The Motley Fool
Dec-07-22 07:45AM Tesla, Apple, GameStop, Prometheus Biosciences, Cassava Sciences: Why These 5 Stocks Are Drawing Investors' Attention TodayBenzinga
Dec-06-22 09:15AM Cassava Sciences Announces Completion of Dosing in Open-label Study of Simufilam for Alzheimer’s DiseaseGlobeNewswire Inc.
Nov-22-22 12:30PM Cassava Sciences Announces Closing of $50 Million Registered Direct OfferingGlobeNewswire Inc.
Nov-18-22 01:30AM Cassava Sciences Announces $50 Million Registered Direct Offering of Common StockGlobeNewswire Inc.
Nov-07-22 09:00AM Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business UpdatesGlobeNewswire Inc.
Nov-04-22 11:17AM Short sellers hit back at Cassava lawsuit against them: ‘We stand behind everything we wrote’MarketWatch
09:49AM Short sellers hit back at Cassava lawsuit against them: ‘We stand behind everything we wrote’MarketWatch
Nov-03-22 09:15AM Cassava Sciences Files Lawsuit Against Perpetrators of “Short and Distort” CampaignGlobeNewswire Inc.
Nov-01-22 02:21AM Cassava Sciences (SAVA) to Report Q3 Earnings: What's in Store?Zacks Investment Research
Oct-27-22 09:15AM Cassava Sciences Announces Expansion of Leadership TeamGlobeNewswire Inc.
Oct-13-22 09:15AM Cassava Sciences Announces Initiation of an Open-label Extension StudyGlobeNewswire Inc.
Oct-07-22 05:29AM 3 Alzheimer Stocks To Buy As The Race For A Cure Heats UpInvesting.com
Oct-06-22 12:41PM Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day SessionBenzinga
04:56AM 3 Alzheimer Stocks To Buy As The Race For A Cure Heats UpInvesting.com
Oct-04-22 02:29AM EXCLUSIVE: Top 10 Stocks Searched On Benzinga Pro In September: Where Do Tesla, Apple, Bed Bath & Beyond Rank?Benzinga
Sep-30-22 10:10AM 'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace CompanyBenzinga
Sep-28-22 05:16AM Should you buy Cassava Sciences as the stock continue to soarInvezz
10:24AM US Stocks Mixed; Wholesale Inventories Increase 1.3% In AugustBenzinga
Sep-28-22 07:17AM Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving PremarketBenzinga
06:13AM Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market SessionBenzinga
Sep-27-22 11:08AM US Stocks Open Higher; Dow Surges 300 PointsBenzinga
Sep-26-22 10:28AM US Stocks Mostly Higher; Nasdaq Rises Over 100 PointsBenzinga
05:08AM BP, Costco, FedEx And Other Big Losers From FridayBenzinga
Sep-26-22 03:43AM Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From FridayBenzinga
Sep-24-22 07:55AM What Happened This Week: The Pound, The Dow, VIX And Even Meta ReactInvesting.com
Sep-23-22 12:16PM Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day SessionBenzinga
12:15PM Nasdaq Tumbles Over 200 Points; Crude Oil Drops SharplyBenzinga
Sep-23-22 10:11AM US Stocks Open Lower; Dow Tumbles 400 PointsBenzinga
03:42AM Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From YesterdayBenzinga
Sep-22-22 03:10AM Dow Turns Higher; Crude Oil Rises 0.7%Benzinga
12:26PM Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day SessionBenzinga
Sep-22-22 11:00AM Trip.com, Albireo Pharma And Some Other Big Stocks Moving Higher On ThursdayBenzinga
Sep-21-22 03:04AM Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From YesterdayBenzinga
Sep-10-22 08:39AM FAANG 2.0: Say Hello To MATANA, And Developments In Apple’s New FrontierInvesting.com
Sep-08-22 09:15AM Cassava Sciences to Present at the H.C. Wainwright Global Investment ConferenceGlobeNewswire Inc.
Sep-03-22 01:24AM Cassava Sciences Looks As Good Of A Purchase As EverSeeking Alpha
Aug-29-22 02:55AM Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From FridayBenzinga
Cassava Sciences, Inc., a clinical-stage drug development company, develops drugs for nervous system disorders. The company's lead therapeutic product candidate PTI-125, a small molecule drug that is in Phase II clinical trial for the treatment of Alzheimer's disease. It is also developing PTI-125Dx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Cap:    |  Volume (24h):